Evidence map›Paper›PMID 33079252›Full record

ArticleWorld journal of urology2021

Health-related quality of life in Japanese low-risk prostate cancer patients choosing active surveillance: 3-year follow-up from PRIAS-JAPAN.

Hiromi Hirama, Mikio Sugimoto, Nobuyuki Miyatake, Takuma Kato, Lionne D F Venderbos, Sebastiaan Remmers, Kenichiro Shiga, Akira Yokomizo, Koji Mitsuzuka, Ryuji Matsumoto and 8 more

Abstract read
PubMed Publisher
In one paragraph

Article in World journal of urology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.1field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 11 citations in OpenAlex.

  1. Trial
  2. Review
  3. Review
  4. Article
  5. Article
  6. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 8 institutions in 2 countries.

Hiromi HiramaDepartment of Urology, Kagawa University Faculty of Medicine, 1750-1 Ikenobe, Kita-gun, Miki-cho, Kagawa, 761-0793, Japan. hirama.hiromi@gmail.com.ORCID http://orcid.org/0000-0003-1047-5002
Mikio SugimotoDepartment of Urology, Kagawa University Faculty of Medicine, 1750-1 Ikenobe, Kita-gun, Miki-cho, Kagawa, 761-0793, Japan.
Nobuyuki MiyatakeDepartment of Hygiene, Faculty of Medicine, Kagawa University Hospital, Miki, Kagawa, Japan.
Takuma KatoDepartment of Urology, Kagawa University Faculty of Medicine, 1750-1 Ikenobe, Kita-gun, Miki-cho, Kagawa, 761-0793, Japan.
Lionne D F VenderbosDepartment of Urology, Erasmus University Medical Center, Rotterdam, The Netherlands.
Sebastiaan RemmersDepartment of Urology, Erasmus University Medical Center, Rotterdam, The Netherlands.ORCID http://orcid.org/0000-0001-9530-6448
Kenichiro ShigaDepartment of Urology, Harasanshin Hospital, Fukuoka, Japan.
Akira YokomizoDepartment of Urology, Harasanshin Hospital, Fukuoka, Japan.
Koji MitsuzukaDepartment of Urology, Tohoku University Graduate School of Medicine, Sendai, Miyagi, Japan.
Ryuji MatsumotoDepartment of Renal and Genito-Urinary Surgery, Graduate School of Medicine, Hokkaido University, Sapporo, Hokkaido, Japan.
Takahiro OsawaDepartment of Renal and Genito-Urinary Surgery, Graduate School of Medicine, Hokkaido University, Sapporo, Hokkaido, Japan.
Takashige AbeDepartment of Renal and Genito-Urinary Surgery, Graduate School of Medicine, Hokkaido University, Sapporo, Hokkaido, Japan.
Hiroshi SasakiDepartment of Urology, Jikei University School of Medicine, Tokyo, Japan.
Shin EgawaDepartment of Urology, Jikei University School of Medicine, Tokyo, Japan.
Iku NinomiyaDepartment of Urology, Shikoku Cancer Center, Matsuyama, Ehime, Japan.
Katsuyoshi HashineDepartment of Urology, Shikoku Cancer Center, Matsuyama, Ehime, Japan.
Monique J RoobolDepartment of Urology, Erasmus University Medical Center, Rotterdam, The Netherlands.ORCID http://orcid.org/0000-0001-6967-1708
Yoshiyuki KakehiDepartment of Urology, Kagawa University Faculty of Medicine, 1750-1 Ikenobe, Kita-gun, Miki-cho, Kagawa, 761-0793, Japan.
Kagawa University · JPErasmus MC · NLHokkaido University · JPHarasanshin Hospital · JPJikei University School of Medicine · JPShikoku Cancer Center · JPKagawa University Hospital · JPTohoku University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeTo evaluate the health-related quality of life (HRQoL) of Japanese men on active surveillance (AS) in the Prostate cancer Research International Active Surveillance study in Japan (PRIAS-JAPAN).

methodsParticipants were included in the PRIAS-JAPAN HRQoL study between January 2010 and March 2016. Their general HRQoL was assessed using a validated Japanese version of the Short-Form 8 Health Survey (SF-8) at enrolment and annually thereafter until discontinuation of AS. The SF-8 mental component summary (MCS) and physical component summary (PCS) of men on AS were compared with scores of the general population (norm-based score [NBS]: 50) and MCS and PCS scores for men following AS were analysed over time. We tested whether MCS and PCS scores over time explained discontinuation of AS.

resultsFive hundred and twenty-five patients enrolled, and the median age at baseline was 68 years. At enrolment and after 1-, 2-, and 3-year follow-ups, the PCS and MCS scores were significantly higher than the NBS of the general Japanese population except for the median PCS at 3 years. We found that age at diagnosis and time on AS negatively affected the PCS score of men on AS, while every additional year on AS led to a 0.27 point increase in MCS scores. Neither PCS nor MCS were predictors for discontinuation of AS.

conclusionJapanese men following an AS strategy for 3 years reported better HRQoL compared with the general population, indicating that monitoring Japanese low-risk prostate cancer patients can be an effective treatment strategy. STUDY REGISTRATION: Clinical trial registry-UMIN (University Hospital Medical Information Network); UMIN000002874 (2009/12/11).

Indexed as

Patient PreferenceQuality of LifeWatchful WaitingAgedFollow-Up StudiesHumansJapanMaleMiddle AgedProspective StudiesProstatic NeoplasmsRisk AssessmentTime FactorsActive surveillanceHRQoLJapanese cohortLow-risk prostate cancerPatient‐reported outcome measurement

Identifiers

PMID33079252
OpenAlexW3093301623

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.